Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.


Strengths

● Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 29% by 2023.

● Analysts covering this company mostly recommend stock overweighting or purchase.


Weaknesses

● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.

● The stock is close to a major daily resistance at USD 104.29, which should be gotten rid of so as to gain new appreciation potential.

● The company's enterprise value to sales, at 3.97 times its current sales, is high.

● The firm trades with high earnings multiples: 42.24 times its 2021 earnings per share.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last few months, analysts have been revising downwards their earnings forecast.

● For the past year, analysts have significantly revised downwards their profit estimates.